A role for neutrophils in asthma exacerbations

[1]  S. Johnston,et al.  Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation , 2017, Nature Medicine.

[2]  M. Raftery,et al.  Neutrophil Extracellular Traps Go Viral , 2016, Front. Immunol..

[3]  E. Bateman,et al.  Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. , 2015, The Lancet. Respiratory medicine.

[4]  N. Papadopoulos,et al.  IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. , 2014, American journal of respiratory and critical care medicine.

[5]  Andrew McKenzie,et al.  Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation , 2014, Science Translational Medicine.

[6]  P. Kubes,et al.  NETosis: how vital is it? , 2013, Blood.

[7]  Ian D Pavord,et al.  Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial , 2012, The Lancet.

[8]  William W Busse,et al.  Role of viral respiratory infections in asthma and asthma exacerbations , 2010, The Lancet.

[9]  P. Gibson,et al.  Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma , 2002, European Respiratory Journal.

[10]  W. Busse,et al.  The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. , 2000, The Journal of allergy and clinical immunology.